New hope for tough RA cases? drug trial targets autoantibodies
Disease control
Ongoing
This study tests an experimental drug called IMVT-1402 in 120 adults with active, difficult-to-treat rheumatoid arthritis (RA) who have a specific antibody (ACPA). The goal is to see if the drug can help control disease activity better than a placebo. Participants will be monitor…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 04, 2026 16:19 UTC